In terms of weight loss effectiveness , semaglutide GLP-1 does have an edge over liraglutide, according to current research
The study design included two rounds of a three-day vehicle-treated baseline phase, a three-day treatment phase, and a two-to-three-day washout phase
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a breakthrough therapy for obesity, overweight, and other associated health conditions, delivering unprecedented weight loss in clinical trials
Some providers use BMI cutoffs, but telehealth platforms like Josie consider symptoms too even with a BMI under 30
If migraines persist despite lifestyle optimization, several clinical approaches may help
Wilson JM, Lin Y, Luo MJ, Considine G, Cox AL, Bowsman LM, et al